申请人:FAB PHARMA S.A.S.
公开号:US20140357617A1
公开(公告)日:2014-12-04
The invention relates to novel heterocyclic acrylamide compounds (I), to the preparation of the compounds and intermediates used therein, to the use of the compounds as antibacterial medicaments and pharmaceutical compositions containing the compounds.
本发明涉及新型杂环丙烯酰胺化合物(I),其制备方法和所使用的中间体,以及将该化合物作为抗菌药物和含有该化合物的制药组合物。